Veradigm | MDRX - PE Price to Earnings


Veradigm reported 11.15 in PE Price to Earnings for its fiscal quarter ending in September of 2022.





Pe Change Date
Alcidion 34.43 41.33 Dec/2025
Ambu A/S 38.1 0.53 Mar/2026
Amplifon 23.29 3.5 Mar/2026
Cardinal Health 30.4 5.87 Mar/2026
Centene 8.66 23.24 Mar/2026
Charles River Laboratories 29.26 14.31 Mar/2026
Cigna 10.56 0.76 Dec/2025
Coloplast 28.44 1.25 Dec/2025
Convatec Group 37.13 9.64 Jun/2024
CVS Health 9.65 4.74 Mar/2026
Diasorin 21.19 5 Mar/2026
Elevance Health 12.4 0.98 Mar/2026
General Electric Aerospace 34.26 4.95 Mar/2026
Gulf Medical Proj 16.48 1.98 Dec/2025
Humana 11.07 14.98 Mar/2026
IQVIA Holdings 19.37 7.21 Mar/2026
Laboratory Of America 25.51 4.65 Mar/2026
Maximus 9.54 6.13 Mar/2026
McKesson 23.85 0.07 Dec/2025
Med Life 282.96 86.55 Dec/2025
Molina Healthcare 23.79 6.34 Mar/2026
Omnicell 56.92 149.77 Mar/2026
Oriola-kd 209.75 148.31 Sep/2024
Owens Minor 120.72 101.99 Sep/2025
Quest Diagnostics 22.4 2.63 Mar/2026
Rede D'or Sao Luiz 13.13 1.7 Mar/2026
Siemens Healthineers 14.62 3.49 Mar/2026
Sonova Holding 25.61 4.39 Jun/2025
Supermax Corporation Bhd 11.24 8.02 Sep/2022
UnitedHealth 15.29 4.5 Mar/2026
Veeva Systems 26.77 9.47 Mar/2026
Veradigm 11.15 4.63 Sep/2022
Xerox 15.1 1.94 Jun/2024